Active Ingredient History

NOW
  • Now
Carprofen is an anti-inflammatory drug developed in Japan by Nippon Roche Research Center. Carprofen, as many NSAIDs, selectively inhibits COX-2 and was shown to suppress inflammation in vitro, using osteoarthritis models. The drug was approved by FDA for human use under the name Ridamyl, however, now it is sold only for veterinary purposes and prescribed for the treatment of postoperative pain and the relief of pain and inflammation associated with osteoarthritis in dogs.   NCATS

  • SMILES: CC(C(O)=O)C1=CC2=C(C=C1)C3=C(N2)C=CC(Cl)=C3
  • InChIKey: PUXBGTOOZJQSKH-UHFFFAOYSA-N
  • Mol. Mass: 273.714
  • ALogP: 4.16
  • ChEMBL Molecule:
More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Oral
  • Pro Drug: No
(+/-)-2-(3-chloro-9h-carbazol-7-yl)propanoic acid | 2-(6-chloro-9h-carbazol-2-yl)-propionic acid | 6-chloro-alpha-methyl-9h-carbazole-2-acetic acid | (+-)-6-chloro-alpha-methylcarbazole-2-acetic acid | 6-chloro-alpha-methylcarbazole-2-acetic acid | c 5720 | carprodyl | carprofen | carprofène | carprofen, (+-)-isomer | carprofeno | carprofen, (r)-isomer | carprofen, (s)-isomer | carprofenum | (+-)-isomer of carprofen | rimadyl | (r)-isomer of carprofen | ro 205720 | ro 20-5720 | ro-205720 | ro-205720000 | (s)-isomer of carprofen

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue